Pertussis in older adults: Prospective study of risk factors and morbidity

Clinical Infectious Diseases

Volumn 55, Issue 11, 2012, Pages 1450-1456

  Liu, Bette C ^a   McIntyre, Peter ^b,c   Kaldor, John M ^a   Quinn, Helen E ^b,c   Ridda, Iman ^b   Banks, Emily ^d,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d The Australian National University   (Australia)

^e SAX INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; AUSTRALIA; BODY MASS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FATALITY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; OBESITY; PERTUSSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; VACCINATION;

AGED; ASTHMA; AUSTRALIA; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW SOUTH WALES; OBESITY; RISK FACTORS; SOCIOECONOMIC FACTORS; WHOOPING COUGH;

EID: 84868195967     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis627     Document Type: Article

References (34)

1. Crowcroft N, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis. Lancet Infect Dis 2003; 3:413-8.
2. Zepp F, Heininger U, Mertsola J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11: 557-70.
3. Thomas P, McIntyre P, Jalaludin B. Survey of pertussis morbidity in adults in western Sydney. Med J Aust 2000; 173:74-6.
4. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182:174-9.
5. Torvaldsen S, McIntyre P. Effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatr Infect Dis J 2003; 22:956-9.
6. Quinn H, McIntyre P. The impact of adolescent pertussis immunization 2004 to 2009-lessons from Australia. Bull World Health Organ 2011; 89:666-74.
7. Hethcote H, Horby P, McIntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 2004; 22:2181-91.
8. Australian Government Department of Health and Ageing. The Australian Immunisation Handbook. 9th ed, Canberra: Australian Government 2008. Available at: http://www.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook- home. Accessed Feb 2012.
9. Australian Institute of Health and Welfare. 2009 Adult vaccination survey: summary results. Canberra: AIHW, 2011.
10. Chiu C, Dey A, Wang H, et al. Vaccine preventable diseases in Australia 2005-2007. Commun Dis Intell 2010; 34:S1-167.
11. Patel A, Rashid S, Godfrey EM, et al. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae genital infections in a publicly funded pregnancy termination clinic: empiric vs. indicated treatment? Contraception 2008; 78:328-31.
12. Gilberg S, Njamkepo E, Parent du Chatelet I, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002; 186:415-8.
13. Nenning M, Shinefield H, Edwards K, Black S, Fireman B. Adult pertussis in an urban population. JAMA 1996; 275:1672-4.
14. Banks E, Redman S, et al. Cohort profile: the 45 and Up Study. Int J Epidemiol 2008; 37:941-7.
15. Australian Bureau of Statistics. 3201.0 - Population by Age and Sex, Australian States and Territories, Jun 2010, 2010. Available at: http://www.abs.gov.au/Ausstats/absnsf/mf/3201.0. Accessed June 2012.
16. Mealing N, Banks E, Jorm L, Steel D, Clements M, Rogers K. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 2010; 10:26.
17. Department of Health and Ageing. National Notifiable Diseases Surveillance System. Available at: www9.health.gov.au/cda/Source/Rpt-4. cfm:25. Accessed January 2012.
18. Sintchenko V. The re-emergence of pertussis: implications for diagnosis and surveillance. NSW Public Health Bull 2008; 19:143-5.
19. Spokes P, Quinn H, McAnulty J. Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations. NSW Public Health Bull 2010; 21:167-73.
20. National Centre for Classification in Health (Sydney). The international statistical classification of diseases and related health problems, 10th revision, Australian modification (ICD-10-AM). 2nd ed. Lidcombe, NSW: National Centre for Classification in Health Sydney, 2000.
21. Centre for Health Record Linkage. Available at: www.cherel.org.au. Accessed Feb 2012.
22. Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-83.
23. Hays R, Liu H, Spritzer K, Cella D. Item response theory analyses of Physical Functioning Items in the Medical Outcomes Study. Med Care 2007; 45:S32-8.
24. Poynten M, Hanlon M, Irwig L, Gilbert G. Serological diagnosis of pertussis: evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection. Epidemiol Infect 2002; 128:161-7.
25. Cornia P, Hersh A, Lipsky B, Newman T, Gonzales R. Does this coughing adolescent or adult patient have pertussis? JAMA 2010; 304:890-6.
26. Cortese M, Baughman A, Brown K, Srivastava P. A 'new age' in pertussis prevention. Am J Prev Med 2007; 32:177-85.
27. de Melker H, Versteegh F, Schellekens J, Teunis P, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 2006; 53: 106-13.
28. Jenkinson D. Natural course of 500 consecutive cases of whooping cough: a general practice population study. BMJ 1995; 310:299-302.
29. Falagas M, Kompoti M. Obesity and infection. Lancet Infect Dis 2006; 6:438-46.
30. Muscatello D, Barr M, Thackway S, MacIntyre C. Epidemiology of influenza- like illness during pandemic (H1N1) 2009, New South Wales, Australia. Emerg Infect Dis 2011; 17:1240-47.
31. Ward J, Cherry J, Chang S, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353:1555-63.
32. Guiso N, Berbers G, Fry N, et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011; 30:307-12.
33. Riffelmann M, Wirsing von Konig C, Guiso N. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005; 43:4925.
34. Njamkepo E, Bonacorsi S, Debruyne M, Gibaud S, Fuillot S, Guiso N. Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis. J Clin Microbiol 2011; 49:4347-8.